Please login to the form below

Not currently logged in
Email:
Password:

Kantar Health Europe appoints chief executive officer

Michel Murino takes on this newly created role

Kantar Health Michel MurinoKantar Health has promoted Michel Murino to the newly created role of chief executive officer for Kantar Health Europe.

Murino will be responsible for overseeing the global healthcare consulting firm's European business with the leaders of all of Kantar Health's European divisions reporting to him.

In this role, he will have a remit to coordinate clients' country-specific business interests in commercial effectiveness, market access, marketing insights and real-world research.

He joined Kantar Health in 1999 as a managing director and has held increasingly senior roles, most recently as chief executive officer for Southern Europe and France.

Global chief executive officer of Kantar Health Lynette Cooke said: “Today, our clients value the breadth of consulting services that Kantar Health can offer on a regional basis, while maintaining expertise of local market requirements and restrictions.

“Michel will lead a regional team to continue to evolve with the industry's needs.”

9th February 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Publicis Resolute

Publicis Resolute provides real-life practical solutions to your issues, without fuss or fluff. We are an experienced team with a...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics